Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-03-020594
Filing Date
2003-09-12
Accepted
2003-09-12 16:07:44
Documents
12
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a03-3330_110ka.htm 10-K/A 110027
3 EX-10.21 a03-3330_1ex10d21.htm EX-10.21 25184
4 EX-10.22 a03-3330_1ex10d22.htm EX-10.22 517863
5 EX-10.23 a03-3330_1ex10d23.htm EX-10.23 219660
6 EX-10.24 a03-3330_1ex10d24.htm EX-10.24 116912
7 EX-10.25 a03-3330_1ex10d25.htm EX-10.25 37261
8 EX-10.26 a03-3330_1ex10d26.htm EX-10.26 13945
9 EX-10.27 a03-3330_1ex10d27.htm EX-10.27 141207
10 EX-10.28 a03-3330_1ex10d28.htm EX-10.28 134760
11 EX-23.1 a03-3330_1ex23d1.htm EX-23.1 3850
12 EX-31.1 a03-3330_1ex31d1.htm EX-31.1 6103
13 EX-31.2 a03-3330_1ex31d2.htm EX-31.2 6945
  Complete submission text file 0001104659-03-020594.txt   1336597
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-15006 | Film No.: 03894106
SIC: 2835 In Vitro & In Vivo Diagnostic Substances